- Home
- EXAS vs EMN Comparison
EXAS vs EMN Comparison
Compare EXAS & EMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXAS
- EMN
- Stock Information
- Founded
- EXAS 1995
- EMN 1920
- Country
- EXAS United States
- EMN United States
- Employees
- EXAS N/A
- EMN N/A
- Industry
- EXAS Medical Specialities
- EMN Major Chemicals
- Sector
- EXAS Health Care
- EMN Industrials
- Exchange
- EXAS Nasdaq
- EMN Nasdaq
- Market Cap
- EXAS 10.5B
- EMN 12.0B
- IPO Year
- EXAS N/A
- EMN 1993
- Fundamental
- Price
- EXAS $49.26
- EMN $98.70
- Analyst Decision
- EXAS Strong Buy
- EMN Buy
- Analyst Count
- EXAS 17
- EMN 13
- Target Price
- EXAS $72.31
- EMN $113.77
- AVG Volume (30 Days)
- EXAS 1.9M
- EMN 1.1M
- Earning Date
- EXAS 02-19-2025
- EMN 01-30-2025
- Dividend Yield
- EXAS N/A
- EMN 3.35%
- EPS Growth
- EXAS N/A
- EMN 2.40
- EPS
- EXAS N/A
- EMN 7.67
- Revenue
- EXAS $2,758,867,000.00
- EMN $9,382,000,000.00
- Revenue This Year
- EXAS $12.09
- EMN $3.27
- Revenue Next Year
- EXAS $11.24
- EMN $4.14
- P/E Ratio
- EXAS N/A
- EMN $12.92
- Revenue Growth
- EXAS 10.37
- EMN 1.87
- 52 Week Low
- EXAS $40.62
- EMN $85.28
- 52 Week High
- EXAS $79.62
- EMN $114.50
- Technical
- Relative Strength Index (RSI)
- EXAS 33.51
- EMN 51.53
- Support Level
- EXAS $45.94
- EMN $98.63
- Resistance Level
- EXAS $51.75
- EMN $103.82
- Average True Range (ATR)
- EXAS 2.13
- EMN 2.20
- MACD
- EXAS -0.30
- EMN -0.10
- Stochastic Oscillator
- EXAS 32.20
- EMN 29.67
About EXAS Exact Sciences Corporation
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a precancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.
About EMN Eastman Chemical Company
Established in 1920 to produce chemicals for Eastman Kodak, Eastman Chemical has grown into a global specialty chemical company with manufacturing sites around the world. The company generates the majority of its sales outside of the United States, with a strong presence in Asian markets. During the past several years, Eastman has sold noncore businesses, choosing to focus on higher-margin specialty product offerings.